Chelsea Shafranek
Medical · Allston, MANPI 1710546411
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 226 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 28 manufacturers, the largest accounting for just 22.2% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2024 at $1,301 and has fallen 69.2% since, to $400 in 2025. Among medical clinicians in MA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 226 payments — averaging $19.70 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$990
- Novo Nordisk$465
- Lilly USA, LLC$400
- AstraZeneca$360
- Pfizer$289
- Sanofi-aventis U.S. LLC$212
- plus $2K from 22 others
What the payments were for
- Food & beverage$4,452100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 55 | $990 |
| Novo Nordisk | 24 | $465 |
| Lilly USA, LLC | 19 | $400 |
| AstraZeneca(2 entities) | 18 | $360 |
| Pfizer | 14 | $289 |
| Sanofi-aventis U.S. LLC | 12 | $212 |
| Bayer | 9 | $174 |
| Boehringer Ingelheim | 7 | $166 |
| Exact Sciences | 7 | $144 |
| Merck | 6 | $130 |
| Johnson & Johnson | 5 | $121 |
| Otsuka America Pharmaceutical, Inc. | 5 | $107 |
| Corium, LLC | 5 | $103 |
| Amgen | 5 | $101 |
| Lundbeck LLC | 4 | $91 |
| GSK | 5 | $91 |
| Amarin Pharma, Inc. | 4 | $81 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 4 | $72 |
| Idorsia Pharmaceuticals US Inc | 3 | $71 |
| Biohaven Pharmaceutical Holding Company Ltd. | 3 | $62 |
| E.r. Squibb & Sons, L.L.C. | 3 | $52 |
| Ardelyx, Inc. | 2 | $45 |
| Novartis | 2 | $32 |
| Daiichi Sankyo Inc. | 1 | $21 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $20 |
| Orexo US, Inc. | 1 | $17 |
| Dexcom, Inc. | 1 | $16 |
| Echosens North America, Inc. | 1 | $16 |
How this compares
$4,452 in reported general payments places this provider in the 95th percentile of 421 medical providers in Massachusetts.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl | 45 | $8,545 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 58 | $1,162 |
| Lidocaine | 12 | $962 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 13 | $558 |
| Acetaminophen-CodeineAcetaminophen With Codeine | 14 | $485 |
| Mirtazapine | 19 | $408 |
| Levothyroxine Sodium | 31 | $294 |
| Eszopiclone | 12 | $291 |
| Gabapentin | 22 | $244 |
| Rosuvastatin Calcium | 13 | $226 |
| Lisinopril | 27 | $192 |
| Atorvastatin Calcium | 23 | $190 |
| Alprazolam | 27 | $166 |
| Clotrimazole | 15 | $156 |
| Oxycodone Hcl | 21 | $149 |
Paid to pharmacies, not to this prescriber.
Other medical in Allston
- Eileen CheeverLeominster$389K
- Vidal PrimiterioLawrence$22K
- Michelle BaytarianJamaica Plain$17K
- Julia FioreAgawam$16K
- Jennifer LevesqueFall River$15K
- Ashley HoffmanWestfield$13K
- Theresa FukudaBoston$13K
- Christina MessingerPlymouth$11K
- Lauren CarraSpringfield$9K
- Raul AliceaSpringfield$9K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.